CoChat

Nanocarriers as an Emerging Platform for Cancer Therapy

Peer, Dan, Karp, Jeffrey M., Hong, Seungpyo, Farokhzad, Omid C., Margalit, Rimona, Langer, Robert · 2020 · Nano-Enabled Medical Applications
Cited by 211

The DOI matches its Crossref record.

Abstract

The delivery of drugs through targeted nanocarriers that are internalized by cells provides an alternative route to diffusion of drugs into cells. Growth factor or vitamin interactions with cancer cells represent a commonly used targeting strategy, as cancer cells often over-express the receptors for nutrition to maintain their fast-growing metabolism. In the case of circulating cancer cells, as in leukaemia and lymphoma, a therapy that targets surface antigens with high affinity and includes a carrier with a long circulating half-life may be the most efficacious. Abraxane is an albumin-bound paclitaxel nanoparticle formulation approved by the Food and Drug Administration in 2005 as a second-line treatment for metastatic breast cancer. The first angiogenesis inhibitor for treating colorectal cancer, Bevacizumab, an anti-VEGF mAb that inhibits the factor responsible for the growth of new blood vessels, was approved in 2004. Expelling drugs inevitably lowers the therapeutic effect and cancer cells soon develop resistance to a variety of drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1201/9780429399039-2

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 211

Metadata

Authors
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R.
Venue
Nano-Enabled Medical Applications
Published
2020-11-23
Pages
61-91
OpenAlex
W4206482224
Cited by
211
References
0
FWCI
19.99
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nanocarriers as an Emerging Platform for Cancer Therapy. https://app.cochat.ai/papers/10.1201/9780429399039-2
The paper
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2020). Nanocarriers as an Emerging Platform for Cancer Therapy. Nano-Enabled Medical Applications. https://doi.org/10.1201/9780429399039-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.